Fluid Pharma is pleased to announce that it will be attending and presenting at the upcoming 12th Annual EuPFI conference. Due to the current Covid-19 pandemic, the conference will be held virtually, however Fluid Pharma will be exhibiting and members of our team will be on hand to discuss our MicroCoatTM technology and collaboration opportunities you may have. In addition, we will be showcasing the technology by showcasing our latest research, with the following abstracts to be presented:
- Rapid Dissolving Capsules for the Administration of Gastro-Resistant Prednisolone Microparticles for Paediatric Patients
- Microparticle-filled straw for the delivery of sustained release metformin for the treatment of Type II Diabetes Mellitus in Paediatric Populations
- Wurster Fluidised Bed Coating of Microparticles: Towards Scalable Production of Oral Sustained-Release Liquid Medicines for Patients with Swallowing Difficulties
If you are not attending and would like to receive a copy of the posters, please contact us at info@fluidpharma.com
About EuPFI (http://www.eupfi.org/)
European Paediatric Formulation Initiative (EuPFI) is a consortium working in a pre-competitive way on paediatric drug formulations. Members are from academia, hospital pharmacies, pharmaceutical industry (Innovators, Generics, Contract Research Organizations (CRO), Specials and Excipient Manufacturers) with European Medicine Agency (EMA) as an observer. It aims to expedite the development of better and safer medicines for children by identifying and scoping issues and challenges in paediatric formulation development. It brings together the voluntary, academic, pharmaceutical industry, hospitals and regulatory agency in order to tackle the development of age-appropriate formulation for paediatrics. It provides funding, expertise and resources to support the solutions to the problems and new technologies emerging from academic research.